Mounjaro and Liver Function: What People on Tirzepatide Should Know

Tirzepatide (the active substance in Mounjaro) acts on GLP-1 and GIP receptors involved in appetite regulation and metabolism. Because these pathways also influence how the body processes fat, there has been meaningful clinical and research interest in how tirzepatide interacts with liver health — particularly in people with fatty liver disease.

Does Mounjaro cause liver damage?

Based on available evidence and the medicine's prescribing information, tirzepatide is not known to cause liver damage in people with otherwise healthy liver function. It is not listed as a common cause of hepatotoxicity in official product information. That said, as with any prescription medicine, rare reactions are possible, and your prescriber is the right person to assess your individual risk profile.

Mounjaro and existing liver disease

People with moderate or severe liver impairment may need additional consideration before starting or continuing tirzepatide. If you have a diagnosed liver condition, your prescriber will have taken this into account when deciding whether to prescribe it. If your circumstances change — for example, if new blood test results raise questions — speak to your healthcare professional promptly rather than adjusting your treatment yourself.

Mounjaro and fatty liver

There is growing research interest in the relationship between GLP-1 receptor agonists and non-alcoholic fatty liver disease (NAFLD) and its more advanced form, metabolic-associated steatohepatitis (MASH). Some early findings have been encouraging, though this is an active area of research and not an established licensed indication. You can read more about this on our dedicated page covering Mounjaro and fatty liver.

Liver-related side effects to be aware of

While liver damage is not a commonly reported side effect, tirzepatide — like many medicines — is subject to ongoing pharmacovigilance. If you notice symptoms such as persistent yellowing of the skin or eyes, unusual upper abdominal pain, or dark urine, contact your healthcare professional promptly. These are not expected effects, but they warrant clinical assessment. You should also report any unexpected side effects to your national reporting scheme (such as the UK's Yellow Card scheme) and to your prescriber.

For a broader overview of tirzepatide and how it works in the body, see our Mounjaro information hub. You may also find it useful to read about liver considerations and Mounjaro in more detail, or about Mounjaro and other health conditions for context on how prescribers weigh individual factors.

When you are living with a health condition — or simply want to stay on top of how your body responds to a new medicine — having a clear record of your symptoms over time is genuinely useful. GLP Trackr's side-effect tracker lets you log how you feel each day, including any abdominal discomfort, fatigue, or other physical changes, and view patterns across your journey.

That log becomes particularly valuable when you have a prescriber appointment coming up. Rather than trying to recall how you felt three weeks ago, you can bring a clear, dated record of your experience — including anything that prompted a question about your liver or your overall health. The app's doctor report feature compiles your tracked data into a summary designed to support those conversations.

You can also use the daily check-in to note energy levels and general wellbeing alongside your dose log, so you build a fuller picture of how tirzepatide is sitting with your body over time.

Important: GLP Trackr helps you record and organise your experience — it is not a substitute for clinical advice. If you have concerns about your liver function or any symptoms that worry you, contact your prescriber or doctor. Any decision about your medication should be made with them, based on your full medical history and test results.

Start logging your journey and bring better information to your next appointment — GLP Trackr is free to try for 7 days on the App Store and Google Play.